http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0063508-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42d31351c76b18378e315027a536c70e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C259-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C255-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C43-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C239-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C43-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C259-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C257-14
filingDate 1982-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f7a1f77ace0d2c496412b5458b36fb7
publicationDate 1982-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0063508-A1
titleOfInvention 4-Phenoxy-3-hydroxy-butyramidoxime derivatives, preparation thereof and use thereof as medicaments
abstract The present invention relates, as new industrial products, to 4-phenoxy-3-hydroxy-butyramidoxime derivatives, characterized in that they are chosen from the group consisting of 4- (allylphenoxy) -3-hydroxy-butyramidoximes of formula and their addition salts.n n n These products are useful in therapy, in particular as antiarrhythmic agents.n n n The compounds of formula I are prepared by reaction of the corresponding butyronitrile with hydroxylamine.
priorityDate 1981-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2210388-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226417690
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236348646
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12592541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54027349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127837471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236344594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68148
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15624
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129028620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54460920
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128440750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54186551
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8008
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129409610
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6328253
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54101690
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128472014
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127392505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226457598
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236338950
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129665268
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54368319
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236342775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13092564
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129404121
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236343184
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236341052
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236342012
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88728850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128908610
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128676068
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37333

Total number of triples: 55.